Student pricing is available for eligible university email holders. View plans

NextSprints
NextSprints Icon NextSprints Logo
Product Design

Master the art of designing products

Product Improvement

Identify scope for excellence

Product Success Metrics

Learn how to define success of product

Product Root Cause Analysis

Ace root cause problem solving

Product Trade-Off

Navigate trade-offs decisions like a pro

All Questions

Explore all questions

Meta (Facebook) PM Interview Course

Practice Meta-focused PM cases

Amazon PM Interview Course

Practice Amazon-focused PM cases

Apple PM Interview Course

Practice Apple-focused PM cases

Google PM Interview Course

Practice Google-focused PM cases

Microsoft PM Interview Course

Practice Microsoft-focused PM cases

All Courses

Explore all courses

1:1 PM Coaching

Practice in a one-to-one session

Resume Review

Narrate impactful stories via resume

Guides Pricing
nextsprints logo

Not a member?

By proceeding, you agree to our Terms of Use and confirm you have read our Privacy and Cookie Statement.

nextsprints logo

Register to continue.

Login with Google Login with LinkedIn

By proceeding, you agree to our Terms of Use and confirm you have read our Privacy and Cookie Statement .

Company focus

Tata 1mg
Product Design Hard Member-only

Design a medically supervised weight-management programme on Tata 1mg.

Prepared by NextSprints

14 mins
Report an error
Clinical Product Design Risk Management Prioritization Health Tech Pharmaceuticals Product-Design Health-Tech Obesity-Care Regulated-Products
Product Management Product Design Question: medically supervised weight management on Tata 1mg

Introduction

Obesity care is one of the fastest-changing areas in Indian healthcare. GLP-1 medicines (the class that includes semaglutide and tirzepatide) have entered the Indian market, generic versions are expected to make them more affordable, and patient demand is high. These are prescription medicines that need medical supervision, regular follow-ups and lifestyle support. Tata 1mg's Specialty Pharma business, which grew about 65% in FY26, already covers obesity management alongside cancer care, adult vaccination and patient support programmes.

The prompt: design a medically supervised weight-management programme on Tata 1mg. This is hard because it combines a clinical product, a regulated medicine, a sensitive personal topic and a business that could easily slip into irresponsible selling. I'll clarify, justify, segment, map pain points, design solutions and define metrics with strong safety guardrails.

Tip

State your guardrails at the start: "I will not design anything that makes prescription weight-loss drugs easier to obtain without proper medical evaluation." It sets the right tone for a health interview.

Step 1

Clarify Questions (3 minutes)

  • Is the programme centred on GLP-1 medicines, or on weight management broadly?

  • Hypothetical answer: Broad weight management, with medication as one option for clinically eligible patients.
  • Impact: The programme must work for patients who are not eligible for medication.
  • Who prescribes?

  • Hypothetical answer: Licensed doctors via 1mg teleconsultation, following Indian telemedicine guidelines; some medicines may need in-person evaluation.
  • What's the business model?

  • Hypothetical answer: Programme fee (monthly or quarterly), plus medicine sales, lab tests and health products.
  • Any constraints?

  • Hypothetical answer: Advertising prescription medicines to consumers is restricted; claims must be accurate.

Propose the Goal

Help eligible adults achieve and sustain clinically meaningful weight loss safely, through supervised care combining doctors, tests, medication (when appropriate), nutrition and coaching.

Define the Scope

In scope: eligibility assessment, consultation, lab tests, prescriptions and refills, coaching, progress tracking. Out of scope: bariatric surgery and hospital care.

Subscribe to access the full answer

Image of author NextSprints

NextSprints

Updated Oct 31, 2026